全文获取类型
收费全文 | 531篇 |
免费 | 62篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 50篇 |
妇产科学 | 7篇 |
基础医学 | 61篇 |
口腔科学 | 29篇 |
临床医学 | 57篇 |
内科学 | 130篇 |
皮肤病学 | 19篇 |
神经病学 | 24篇 |
特种医学 | 78篇 |
外科学 | 53篇 |
综合类 | 21篇 |
预防医学 | 14篇 |
药学 | 32篇 |
中国医学 | 1篇 |
肿瘤学 | 15篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 9篇 |
2020年 | 3篇 |
2019年 | 9篇 |
2018年 | 9篇 |
2017年 | 8篇 |
2016年 | 7篇 |
2015年 | 12篇 |
2014年 | 16篇 |
2013年 | 24篇 |
2012年 | 15篇 |
2011年 | 23篇 |
2010年 | 48篇 |
2009年 | 28篇 |
2008年 | 16篇 |
2007年 | 11篇 |
2006年 | 14篇 |
2005年 | 14篇 |
2004年 | 11篇 |
2003年 | 9篇 |
2002年 | 8篇 |
2001年 | 3篇 |
2000年 | 5篇 |
1999年 | 9篇 |
1998年 | 30篇 |
1997年 | 35篇 |
1996年 | 34篇 |
1995年 | 27篇 |
1994年 | 18篇 |
1993年 | 17篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 12篇 |
1988年 | 15篇 |
1987年 | 15篇 |
1986年 | 12篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 10篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1972年 | 1篇 |
1969年 | 1篇 |
1954年 | 1篇 |
排序方式: 共有600条查询结果,搜索用时 0 毫秒
101.
Maulik R. Patel Yagnik S. Bhalodia Nimish L. PathakMaulik S. Patel Kunal SutharNilesh Patel Dharmesh K. GolwalaNurudin P. Jivani 《Journal of ethnopharmacology》2013
Ethnopharmacological relevance
In the traditional medicine, Cynodon dactylon (Linn.) is used in asthma, but scientific studies to provide evidence for medicinal uses are sparse. Thus this study was undertaken to provide evidence for medicinal use in asthma as a bronchodilator, and to identify active ingredient(s).Materials and methods
In vivo, acetylcholine (Ach)-induced bronchospasm was conducted in guinea pig while isolated rat tracheal strip was suspended in organ bath to measure the concentration response curve using multichannel data acquisition system.Results
The chloroform extract of Cynodon dactylon (CECD) protected against Ach-induced bronchospasm in guinea pigs, similar to atropine. In the in vitro studies, CECD relaxed carbachol (CCh) and high K+-induced contraction of rat tracheal strip, similar to atropine and verapamil respectively, suggesting antimuscarinic and calcium channel blocking (CCB) activities, which were confirmed by right ward shifting of CCh and Ca+2 concentration response curve (CRC). The phosphodiestrase (PDE) inhibitory activity was confirmed by potentiation of isoprenaline-induced inhibitory response, similar to papaverine. Densitometry analyses led to the identification of scopoletin as an active ingredient. Effectively, it significantly inhibited high K+, and Ca+2 induced contractile response, similar to verapamil. The phosphodiestrase (PDE) inhibitory activity was confirmed by direct evidence of potentiation of isoprenaline-induced inhibitory response, similar to papaverine.Conclusions
These results suggest that the bronchodilator activity of CECD is partly due to presence of scopoletin, and mediated possibly through CCB and PDE inhibition. 相似文献102.
103.
104.
Ronan MG Berg Sarah Taudorf Damian M Bailey Carsten Lundby Fin Stolze Larsen Bente Klarlund Pedersen Kirsten Møller 《Critical care (London, England)》2010,14(1):R16
Introduction
Alterations in circulating large neutral amino acids (LNAAs), leading to a decrease in the plasma ratio between branched-chain and aromatic amino acids (BCAA/AAA ratio), may be involved in sepsis-associated encephalopathy. We hypothesised that a decrease in the BCAA/AAA ratio occurs along with a net cerebral influx of the neurotoxic AAA phenylalanine in a human experimental model of systemic inflammation. 相似文献105.
Pro-inflammatory and pro-apoptotic mediators have been involved in the pathogenesis of neurodegenerative diseases. Tigecycline (Tig), a glycylcycline antibiotic and an analog of Minocycline, is shown to exert anti-inflammatory effects that are distinct from its anti-microbial activity. Its neuroprotective mechanism is unknown. In this study, we investigated the direct protective mechanisms of tigecycline against lipopolysaccharide (LPS)-induced Rat pheochromocytoma (PC12) cells. The results showed that tigecycline significantly attenuated the expression and the release of nuclear factor-kappa beta (NF-κB), tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β), as well as nitric oxide (NO) levels in LPS-induced PC12 cells. In addition, tigecycline dose-dependently decreased cytochrome c release and caspase-3 activity. This later finding corroborated the results of decreased pro-apoptotic Bad, and increased anti-apoptotic Bcl-2 protein expression thus, confirming a neuroprotective effect of the drug in differentiated PC12 cells induced with LPS. The findings of our study suggest new targets for tigecycline and support the potential for tigecycline to be investigated as a therapeutic agent for neurodegenerative disorders. 相似文献
106.
107.
108.
109.
110.